Skip to main content

AC Immune SA

ACIU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001651625

No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding AC Immune SA changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of ACIU: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5764+7
Shares18.2M17.7M−534.0K (−2.9%)
Value$144.3M$118.5M−$25.8M (−17.9%)

New holders (15)

Institutions that held AC Immune SA at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ACIU in Q3 2021
InstitutionSharesValue% of portfolio
Suvretta Capital Management, LLC963,500$6.46M0.11%
Price T Rowe Associates Inc396,919$2.66M0.00%
Eversept Partners, LP221,749$1.49M0.12%
Bellevue Group AG139,000$933.0K0.01%
Sphera Funds Management Ltd.121,019$812.0K0.08%
Walleye Capital LLC58,508$393.0K0.01%
Verition Fund Management LLC56,744$381.0K0.01%
Pura Vida Investments, LLC35,000$235.0K0.02%
Jump Financial, LLC31,600$212.0K0.02%
TD Asset Management Inc28,900$194.0K0.00%
ACT Capital Management, LLC21,500$144.0K0.07%
BNP Paribas Arbitrage, SA13,642$91.5K0.00%
Two Sigma Securities, LLC11,276$76.0K0.02%
MV Capital Management, Inc.1,340$9.00K0.00%
The PNC Financial Services Group, Inc.1$00.00%

Sold out (8)

Institutions that held AC Immune SA at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of ACIU in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Ikarian Capital, LLC196,208$1.56M
Vident Investment Advisory, LLC25,974$206.0K
Boothbay Fund Management, LLC22,079$175.0K
HRT Financial LP18,878$149.0K
Trexquant Investment LP13,643$108.0K
National Asset Management, Inc.10,500$84.0K
Group One Trading, L.P.5,577$44.0K
Mirae Asset Global Investments Co., Ltd.1,181$9.00K